/

EDTXF

Spectral Medical Inc.After hours

0.7760−0.02 −3.00%USD

OTC Markets OTCPK · as of Oct 13, 16:00 ET · 15m delay

Open

0.7700

Prev close

0.8000

Day range

0.77000.8000

52-week range

0.64701.15

Volume

4.61K0.45×

Mkt cap

227.80M

P/E ttm

—

Fwd P/E

—

EPS ttm

-0.0900

Div yield

0.00%

Earnings

Aug 7, 2026

From 52w high

−32.52%

Price Chart

Yahoo Finance · delayed

EDTXFOct 13, 2026O 0.7970H 0.7970L 0.7760C 0.7760−0.0240 (−3.00%)Vol 2.50K

SMA 500.9035
SMA 2000.9658

1Y change −6.51% since Oct 13, 2025 close539 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

EDTXF Spectral Medical Inc. · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −8.60%
1 month: −14.35%
3 months: −18.32%
6 months: −23.17%
Year to date: −25.38%
1 year: −6.51%

Valuation & ownership

Market cap: 227.80M
Enterprise value: 251.64M
P/E (ttm): —
Forward P/E: —
PEG ratio: —
Price / book: —
Price / sales (ttm): 88.67
EV / EBITDA: -24.33
EPS (ttm): -0.0900
EPS (forward): —
Beta (5y monthly): 0.22
Dividend yield: 0.00%
Payout ratio: 0.00%
Shares outstanding: 293.55M
Float: 288.11M
Short % of float: —
Short ratio (days): —
Held by insiders: 17.21%
Held by institutions: 12.39%
Avg volume (3m): 10.16K
50-day average: 0.9035
200-day average: 0.9658
52-week change: −6.51%
S&P 500 52-week: +17.00%

Technicals (daily)

RSI (14): 36.4
vs 50-day SMA: −14.11%
vs 200-day SMA: −19.65%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▲ above
ATR (14) % of price: 3.31%
Realised vol (20d, ann.): 57.2%
From 52-week high: −32.52%
From 52-week low: +19.94%

ANR

Analyst Consensus

No analyst coverage for this instrument.

Financial Snapshot

Full statements →trailing twelve months

Revenue (ttm): 2.57M
Revenue growth (yoy): −23.60%
Earnings growth (yoy): —
Gross margin: 53.13%
Operating margin: -338.65%
Profit margin: 0.00%

DES

About Spectral Medical Inc.

Yahoo Finance profile

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

Sector: Healthcare
Industry: Diagnostics & Research
Employees: 29
Headquarters: Toronto, ON, Canada
Website: spectraldx.com
Officers: Mr. Christopher Seto CEO, Interim CFO & Director
Prof. John A. Kellum M.D. Chief Medical Officer

SEAS

Seasonality · EDTXF

2009–2026 · monthly returns

Strongest month Dec +8.19%Weakest month Oct −4.84%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	-9.6	3.2	1.4	0.4	5.7	-12.2	7.9	-2.1	-16.1	-4.4			−25.4%
2025	6.6	27.0	9.6	12.6	6.2	-1.9	1.0	77.0	0.9	-2.8	-15.1	15.6	+199.7%
2024	25.0	5.0	-18.3	-0.9	1.8	2.0	5.9	33.7	-10.0	-3.1	-6.0	-15.4	+8.4%
2023	-9.7	-5.0	-0.4	-17.0	15.8	16.8	-6.6	19.2	-11.5	-6.3	21.9	10.7	+19.4%
2022	15.3	21.2	-4.5	4.3	-6.1	34.3	33.0	-17.3	-14.4	-1.7	-11.2	5.5	+52.3%
2021	16.4	36.5	-14.9	-1.6	-11.3	14.1	-27.8	-15.9	-5.4	-4.9	-20.5	-5.4	−44.7%
2020	-9.6	-4.9	-32.7	43.9	-3.2	-11.5	-9.1	11.9	-18.1	-19.8	7.0	9.3	−44.2%
2019	25.5	36.7	-18.4	-10.0	11.1	-3.6	10.4	-4.7	7.7	23.9	20.1	25.3	+185.0%
2018	-1.9	-0.3	-20.1	6.8	-7.5	25.5	-16.1	-7.7	-6.3	-6.2	-15.2	11.7	−37.5%
2017	-5.0	3.3	47.2	25.8	2.8	-20.9	-2.8	-2.8	4.2	-7.2	-13.1	24.0	+45.5%
2016	-11.2	-1.0	13.7	20.0	11.1	-6.9	23.2	-3.9	46.7	-86.1	-13.8	46.7	−62.1%
2015	1.0	63.3	41.7	10.0	1.3	-12.7	-8.3	1.5	-8.8	4.6	6.6	-7.5	+99.3%
2014	-29.1	-25.1	-7.5	4.1	-7.5	34.6	-4.3	-2.7	-7.7	-7.0	21.1	-14.2	−47.1%
2013	1.5	-13.9	7.4	-12.2	18.5	5.5	27.4	36.6	-9.1	15.9	13.7	-2.3	+109.9%
2012	21.0	-8.7	-2.6	0.4	-11.9	25.5	-17.5	22.7	-3.9	-13.1	-7.1	33.0	+24.8%
2011	-14.9	-0.7	16.7	-5.1	-22.0	-6.9	14.9	-9.7	-16.0	45.2	-12.1	-21.6	−40.8%
2010	0.0	-11.5	39.3	-10.8	-16.3	-21.3	-6.4	-12.2	22.6	-8.9	-11.3	15.6	−31.7%
2009													—

INSD

Insider Activity · EDTXF

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

0 shares

Sells, 6 months

— shares

Net shares

Net change in insider shares

—

Date	Insider	Transaction	Shares	Value
Aug 24, 2026	Stevens (William Charles)Director of Issuer	—	100K	—
Aug 19, 2026	Seto (Chris)Senior Officer of Issuer	—	253.2K	—
Aug 19, 2026	Seto (Chris)Senior Officer of Issuer	Disposition in the public market at price 0.95 per share.	164.6K	$156.42K
Aug 18, 2026	Seto (Chris)Senior Officer of Issuer	—	201K	—
Aug 18, 2026	Seto (Chris)Senior Officer of Issuer	Disposition in the public market at price 0.98 per share.	157.3K	$154.94K
Jul 7, 2026	Walker (Paul M.)Director of Issuer	Exercise of options at price 0.96 per share.	372.3K	$357.45K
Feb 18, 2026	Gupta (Medha)Senior Officer of Issuer	Exercise of options at price 0.99 per share.	13.3K	$13.16K
Jan 21, 2026	Kellum (John)Senior Officer of Issuer	—	400K	—
Jan 21, 2026	Kellum (John)Senior Officer of Issuer	Disposition in the public market at price 0.94 per share.	248.7K	$234.27K
Jan 14, 2026	Gupta (Medha)Senior Officer of Issuer	—	39.3K	—
Jan 14, 2026	Walker (Paul M.)Director of Issuer	—	85.4K	—
Dec 31, 2025	Gupta (Medha)Senior Officer of Issuer	—	13.3K	—

EDTXF

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

EDTXF

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About Spectral Medical Inc.

Seasonality · EDTXF

Insider Activity · EDTXF

Congress Trades · EDTXF

Investors Holding EDTXF

Investors Holding EDTXF

Congress Trades · EDTXF

Insider Activity · EDTXF

Seasonality · EDTXF

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About Spectral Medical Inc.

Earnings & Dividends

News